- Home
- AMC vs IRON Comparison
AMC vs IRON Comparison
Compare AMC & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMC
- IRON
- Stock Information
- Founded
- AMC 1920
- IRON 2017
- Country
- AMC United States
- IRON United States
- Employees
- AMC N/A
- IRON N/A
- Industry
- AMC Movies/Entertainment
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- AMC Consumer Discretionary
- IRON Health Care
- Exchange
- AMC Nasdaq
- IRON Nasdaq
- Market Cap
- AMC 1.5B
- IRON 1.8B
- IPO Year
- AMC 2013
- IRON N/A
- Fundamental
- Price
- AMC $2.82
- IRON $51.38
- Analyst Decision
- AMC Hold
- IRON Strong Buy
- Analyst Count
- AMC 7
- IRON 10
- Target Price
- AMC $3.92
- IRON $93.40
- AVG Volume (30 Days)
- AMC 8.6M
- IRON 411.3K
- Earning Date
- AMC 08-01-2025
- IRON 08-07-2025
- Dividend Yield
- AMC N/A
- IRON N/A
- EPS Growth
- AMC N/A
- IRON N/A
- EPS
- AMC N/A
- IRON N/A
- Revenue
- AMC $4,548,300,000.00
- IRON N/A
- Revenue This Year
- AMC $8.36
- IRON N/A
- Revenue Next Year
- AMC $6.63
- IRON N/A
- P/E Ratio
- AMC N/A
- IRON N/A
- Revenue Growth
- AMC N/A
- IRON N/A
- 52 Week Low
- AMC $2.45
- IRON $30.82
- 52 Week High
- AMC $5.76
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- AMC 36.88
- IRON 56.63
- Support Level
- AMC $2.95
- IRON $52.52
- Resistance Level
- AMC $3.14
- IRON $55.52
- Average True Range (ATR)
- AMC 0.11
- IRON 2.39
- MACD
- AMC -0.04
- IRON 0.03
- Stochastic Oscillator
- AMC 4.24
- IRON 61.58
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.